글로벌 독서 장애 치료 시장 – 2030년까지의 산업 동향 및 예측

독서 장애 치료 시장 분석 및 규모

통계에 따르면 전 세계적으로 10명 중 1명이 난독증을 앓고 있습니다. 난독증이 있는 어린이의 25~40%는 주의력 결핍 과잉 행동 장애도 있고, ADHD가 있는 어린이의 약 25%는 난독증도 있습니다. 미국 보스턴 컨설팅 그룹이 2020년 7월에 발표한 보고서 "캘리포니아에 대한 난독증의 경제적 영향"에 따르면, 난독증은 2020년에 캘리포니아에 약 120억 달러, 향후 60년 동안 1조 달러의 손실을 가져올 것으로 예상됩니다. 그 결과, 예측 기간 내에 신흥 경제권에서 난독증에 대한 인식이 높아짐에 따라 특정 진단율이 증가할 것으로 예상됩니다. 난독증을 치료하기 위한 애플리케이션 개발 노력도 시장을 활성화하고 있습니다.

Data Bridge Market Research는 2022년에 4,096.1백만 달러였던 난독증 치료 시장이 2030년까지 6,677.85백만 달러에 도달할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 6.3%의 CAGR을 기록할 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

독서 장애 치료 시장 범위 및 세분화      

시장 정의

난독증은 익숙하지 않거나 어려운 단어를 기억하고, 읽고, 쓰는 데 어려움을 겪는 것입니다. 이 신경 학습 질환은 여러 계층의 사람들에게 영향을 미칩니다. 난독증이 있는 어린이는 전문적인 교육 방법을 통해 조기에 개입할 수 있습니다. 연구자들은 이러한 어려움을 극복하기 위해 노력하고 있는데, 왜냐하면 두 명의 난독증 청소년이 동일한 증상을 보이지 않기 때문입니다. 약물과 중추 신경계 자극제는 난독증과 ADHD에 자주 권장되지만, 두 질환 모두에 대한 알려진 치료법은 없습니다.

독서 장애 치료 시장 동향

운전자

• 증가하는 의료 인프라는 성장을 뒷받침할 것입니다.

난독증 치료에 대한 글로벌 시장은 의료 인프라 개발 지출 증가와 질병별 새로운 치료법에 대한 수요 증가로 인해 확대되고 있습니다. 개인의 가처분 소득 증가와 이 상태에 대한 충족되지 않은 큰 수요는 수익성 있는 시장 확대를 만들어내는 추가적인 간접적 요인입니다. 유타주 난독증 센터에 따르면 난독증은 가장 흔한 언어 기반 학습 문제입니다. 독서에 어려움을 겪는 사람의 약 70~80%가 난독증입니다. 5명 중 1명의 학생, 즉 인구의 15~20%가 언어 기반 학습 문제를 가지고 있습니다. 남녀 모두 난독증 유병률은 거의 같습니다. 또한 전국 교육 진도 평가(NAEP)에 따르면 4학년 학생의 38%가 "기본 이하" 독서 능력을 가지고 있습니다.

• 난독증 치료에 대한 수요 증가는 시장 성장을 촉진할 것입니다

The cost to society of the failure to master fundamental reading abilities throughout school years is also expected to increase the need for dyslexia treatment. As an illustration, in the UK, the expenditure per person up to the age of 37 is between US$6746 AND US$58,015.60 and between US$6746 throughout the life of individual. as a result, the usd value increases from US$267.14 million to US$3.37 billion.

Opportunities

• Rising in specific diagnostic rate is a promising opportunity

Since emerging economies are expected to become more aware of dyslexia throughout the forecast period, the specific diagnostic rate is expected to increase. The market is also being fuelled by increased efforts to create applications to treat dyslexia. The specific diagnostic rate is predicted to rise because emerging economies are anticipated to become more aware of dyslexia during the forecast period.

Restraints/Challenges

• Side-effects associated with dyslexia treatment

Having trouble in reading, even when reading aloud is one of the dyslexia symptoms and signs that affects teens and adults frequently. Writing and reading that takes a lot of effort. Spelled incorrectly refraining from reading-related activities, errors in pronunciation, difficulties in word retrieval, among others are the side effects of dyslexia treatment.

The development of vocabulary and background information may be hampered by secondary effects such as reading comprehension issues and a decreased reading pleasure. The ability and drive required to learn to read are there in a person with dyslexia, but they struggle with reading and writing.

This dyslexia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dyslexia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Dyslexia Treatment Market Scope

The dyslexia treatment market is segmented on the basis of type, therapy type, drug class, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Double Deficit Dyslexia
• Visual Dyslexia
• Phonological Dyslexia
• Others

 Therapy Type

• Occupational Therapy
• Speech Therapy
• Cognitive Behavioural Therapy

Drug Class

• Antihistamine
• Central Nervous Stimulant
• Anti-Myoclonic
• Others

 Drugs

• Cyclizine
• Meclizine
• Dimenhydrinate
• Methylphenidate
• Others

 Route of Administration

• Oral
• Injectable

 End Users

• Psychiatric Institutions
• Rehabilitation Centres
• Home Care 
• Others

 Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Dyslexia Treatment Market Regional Analysis/Insights

The dyslexia treatment market is analysed and market size insights and trends are provided by country, type, therapy type, drug class, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the dyslexia treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the dyslexia treatment market due to the increased costs for developing research and development capabilities, high prevalence of dyslexia and also due to the availability of high-tech devices. Additionally, rising public awareness and an increase in the number of students enrolled in special education programmes contribute to the expansion of the region in this market.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rising healthcare infrastructure development costs, an increase in the prevalence of neurological illnesses and rising personal disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Dyslexia Treatment Market Share Analysis

The dyslexia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dyslexia treatment market.

난독증 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 다케다제약 주식회사(일본)
• GSK plc (영국)
• 루팡(인도)
• 릴리(미국)
• Sun Pharmaceutical Industries Ltd. (인도)
• 노바티스 AG(스위스)
• 아스트라제네카(영국)
• 파이저 주식회사(미국)
• 엔도제약(미국)
• Amneal Pharmaceuticals LLC(미국)
• 비온파마(미국)
• ANI Pharmaceuticals, Inc. (미국)
• Viatris Inc. (미국)
• Breckenridge Pharmaceutical, Inc. (미국)
• Ironshore Pharmaceuticals Inc. (미국)
• Alkem Labs(인도)
• 멀린크로트(영국)
• 알보젠(미국)

SKU-47748